Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    gastroenterology

    Colorectal cancer

    Also known as: Colorectal carcinoma, Colon cancer, Rectal cancer, Large bowel cancer

    Colorectal cancer comprises malignant neoplasms of the colon or rectum, requiring definitive staging and oncology-led management. Primary interventions include surgical resection, systemic therapies, and potentially radiotherapy for rectal lesions. Chinese medicine is utilised strictly as an adjunctive modality for symptom management, not for antineoplastic control. Recent investigation into electroacupuncture demonstrated modest improvements in gastrointestinal symptoms over a three-day period during chemotherapy, although these failed to meet prespecified thresholds for clinical significance [2]. Research concerning the microbiome, herbal decoctions, and emodin is currently limited to preclinical models and does not establish clinical efficacy or prophylactic benefit [1,3,4]. The traditional patterns described herein serve as frameworks for symptom categorisation rather than oncological subtypes; associated acupuncture point protocols and herbal formulas remain unvalidated by the cited evidence.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain a precise record of bowel frequency, stool consistency, emesis/nausea severity, fluid intake, and use of rescue medications for oncology review.
    • •Prioritise intake of tolerated, nutrient-dense foods and seek dietitian referral for falling weight or reduced intake; avoid restrictive 'anticancer' diets.
    • •Engage in appropriate levels of physical activity and rest, adhering strictly to postoperative restrictions and oncological recommendations.
    • •Adhere to individualised stoma care, hydration, and bowel management protocols; do not initiate high-fibre supplementation, probiotics, or laxative herbs without professional consultation.

    Cautions & Contraindications

    See sources
    • •Defer needling during suspected infection, clinically significant neutropenia, thrombocytopenia or active bleeding until the oncology team confirms suitability. The absence of serious adverse events in the short trial [2] does not establish safety in these populations or provide blood-count thresholds.[]
    • •Avoid needling through tumours, infected or irradiated damaged skin, surgical wounds, stomas and vascular-access sites. Obtain clearance after abdominal surgery and for electroacupuncture with implanted electronic devices. These are general precautions, not protocols established by the supplied abstract [2].[]
    • •Do not use emodin or Ma Zi Ren Wan as anticancer treatment or extrapolate mouse lifespan findings to patients. Laxative botanicals require medical review, particularly with suspected obstruction, diarrhoea or dehydration; the preclinical study does not establish clinical safety or benefit.[]
    • •Do not introduce experimental microbiome products or herbal anticancer regimens on the basis of tumour-cell, organoid or animal findings. These supplied studies establish neither patient benefit nor compatibility with oncology medicines.[,]

    When to reassess or seek care again

    See sources

    Record baseline nausea on a 0–10 scale, stool frequency and Bristol type, oral intake, rescue medicine use and functional interference. Review within 48–72 hours during chemotherapy and before each subsequent session; monitor weight weekly if nutritional risk is present. Escalate worsening symptoms, falling intake or weight, or increased rescue medicine use to oncology rather than intensifying complementary treatment. Stop or revise adjunctive care if no worthwhile symptom improvement after one treatment cycle; any red flag requires immediate assessment.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Nature metabolism · 2026
    2. Journal of the National Cancer Institute · 2026
    3. Journal of ethnopharmacology · 2026
    4. The American journal of Chinese medicine · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.